{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:56:20Z","timestamp":1794362180035,"version":"4.9.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T00:00:00Z","timestamp":1649980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s00415-022-11120-z","type":"journal-article","created":{"date-parts":[[2022,4,15]],"date-time":"2022-04-15T07:02:46Z","timestamp":1650006166000},"page":"4836-4845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson\u2019s disease: a cross-sectional and longitudinal study"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4633-3340","authenticated-orcid":false,"given":"Fardin","family":"Nabizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasra","family":"Pirahesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parya","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,15]]},"reference":[{"issue":"8","key":"11120_CR1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/S00702-017-1686-Y","volume":"124","author":"OB Tysnes","year":"2017","unstructured":"Tysnes OB, Storstein A (2017) Epidemiology of Parkinson\u2019s disease. J Neural Transm 124(8):901\u2013905. https:\/\/doi.org\/10.1007\/S00702-017-1686-Y","journal-title":"J Neural Transm"},{"issue":"5","key":"11120_CR2","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.WNL.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM (2007) Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 68(5):384\u2013386. https:\/\/doi.org\/10.1212\/01.WNL.0000247740.47667.03","journal-title":"Neurology"},{"issue":"6","key":"11120_CR3","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LML de Lau","year":"2006","unstructured":"de Lau LML, Breteler MMB (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535. https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"issue":"1","key":"11120_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/JAMANEUROL.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson pandemic\u2014a call to action. JAMA Neurol 75(1):9\u201310. https:\/\/doi.org\/10.1001\/JAMANEUROL.2017.3299","journal-title":"JAMA Neurol"},{"key":"11120_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/J.PNEUROBIO.2015.07.003","volume":"155","author":"M Bourdenx","year":"2017","unstructured":"Bourdenx M, Koulakiotis NS, Sanoudou D, Bezard E, Dehay B, Tsarbopoulos A (2017) Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies. Prog Neurobiol 155:171\u2013193. https:\/\/doi.org\/10.1016\/J.PNEUROBIO.2015.07.003","journal-title":"Prog Neurobiol"},{"issue":"1","key":"11120_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/MDS.26369","volume":"31","author":"N Shah","year":"2016","unstructured":"Shah N, Frey KA, LTM m\u00fcller M, Petrou M, Kotagal V, Koeppe RA, Scott PJH, Albin RL, Bohnen NI (2016) Striatal and cortical \u03b2-amyloidopathy and cognition in Parkinson\u2019s disease. Mov Disord 31(1):111\u2013117. https:\/\/doi.org\/10.1002\/MDS.26369","journal-title":"Mov Disord"},{"key":"11120_CR7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.3389\/FNEUR.2018.00809\/BIBTEX","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Gao F, Wang D, Li C, Fu Y, He W, Zhang J (2018) Tau pathology in Parkinson\u2019s disease. Front Neurol 9:809\u2013809. https:\/\/doi.org\/10.3389\/FNEUR.2018.00809\/BIBTEX","journal-title":"Front Neurol"},{"issue":"2","key":"11120_CR8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ana.21192","volume":"62","author":"A Goris","year":"2007","unstructured":"Goris A, Williams-Gray CH, Clark GR, Foltynie T, Lewis SJG, Brown J, Ban M, Spillantini MG, Compston A, Burn DJ, Chinnery PF, Barker RA, Sawcer SJ (2007) Tau and \u03b1-synuclein in susceptibility to, and dementia in. Parkinson\u2019s Dis Ann Neurol 62(2):145\u2013153. https:\/\/doi.org\/10.1002\/ana.21192","journal-title":"Parkinson's Dis Ann Neurol"},{"issue":"5","key":"11120_CR9","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1378\/CHEST.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146(5):1387\u20131394. https:\/\/doi.org\/10.1378\/CHEST.14-0970","journal-title":"Chest"},{"issue":"2","key":"11120_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/BRAIN\/AWL363","volume":"130","author":"VC De Cock","year":"2007","unstructured":"De Cock VC, Vidailhet M, Leu S, Texeira A, Apartis E, Elbaz A, Roze E, Willer JC, Derenne JP, Agid Y, Arnulf I (2007) Restoration of normal motor control in Parkinson\u2019s disease during REM sleep. Brain 130(2):450\u2013456. https:\/\/doi.org\/10.1093\/BRAIN\/AWL363","journal-title":"Brain"},{"issue":"1","key":"11120_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12883-017-0795-4","volume":"17","author":"J Zhang","year":"2017","unstructured":"Zhang J, Xu C-Y, Liu J (2017) Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson\u2019s disease. BMC Neurol 17(1):23. https:\/\/doi.org\/10.1186\/s12883-017-0795-4","journal-title":"BMC Neurol"},{"issue":"2","key":"11120_CR12","doi-asserted-by":"publisher","first-page":"e89741","DOI":"10.1371\/journal.pone.0089741","volume":"9","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Fern\u00e1ndez-Arcos A, Tolosa E, Serradell M, Molinuevo JL, Valldeoriola F, Gelpi E, Vilaseca I, S\u00e1nchez-Valle R, Llad\u00f3 A, Gaig C, Santamar\u00eda J (2014) Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS ONE 9(2):e89741. https:\/\/doi.org\/10.1371\/journal.pone.0089741","journal-title":"PLoS ONE"},{"issue":"5","key":"11120_CR13","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/ana.24385","volume":"77","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel W, Dauvilliers Y, Ju YE, Puligheddu M, Sonka K, Pelletier A, Santamaria J, Frauscher B, Leu-Semenescu S, Zucconi M, Terzaghi M, Miyamoto M, Unger MM, Carlander B, Fantini ML, Montplaisir JY (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77(5):830\u2013839. https:\/\/doi.org\/10.1002\/ana.24385","journal-title":"Ann Neurol"},{"issue":"8","key":"11120_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/J.SLEEP.2012.10.009","volume":"14","author":"CH Schenck","year":"2013","unstructured":"Schenck CH, Boeve BF, Mahowald MW (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 14(8):744\u2013748. https:\/\/doi.org\/10.1016\/J.SLEEP.2012.10.009","journal-title":"Sleep Med"},{"issue":"5","key":"11120_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/MDS.27018","volume":"32","author":"EK St Louis","year":"2017","unstructured":"St Louis EK, Boeve AR, Boeve BF (2017) REM sleep behavior disorder in Parkinson\u2019s disease and other synucleinopathies. Mov Disord 32(5):645\u2013658. https:\/\/doi.org\/10.1002\/MDS.27018","journal-title":"Mov Disord"},{"key":"11120_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.01.018","volume":"62","author":"A Duarte Folle","year":"2019","unstructured":"Duarte Folle A, Paul KC, Bronstein JM, Keener AM, Ritz B (2019) Clinical progression in Parkinson\u2019s disease with features of REM sleep behavior disorder: a population-based longitudinal study. Parkinsonism Relat Disord 62:105\u2013111. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.01.018","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"11120_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/ANA.22311","volume":"69","author":"M Shi","year":"2011","unstructured":"Shi M, Bradner J, Hancock AM, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Zabetian CP, Kim HM, Leverenz JB, Montine TJ, Ginghina C, Kang UJ, Cain KC, Wang Y, Aasly J, Goldstein D, Zhang J (2011) Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol 69(3):570\u2013580. https:\/\/doi.org\/10.1002\/ANA.22311","journal-title":"Ann Neurol"},{"key":"11120_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/FNAGI.2014.00053\/BIBTEX","volume":"6","author":"L Parnetti","year":"2014","unstructured":"Parnetti L, Farotti L, Eusebi P, Chiasserini D, De Carlo C, Giannandrea D, Salvadori N, Lisetti V, Tambasco N, Rossi A, Majbour NK, El-Agnaf O, Calabresi P (2014) Differential role of CSF alpha-synuclein species, tau, and A\u03b242 in Parkinson\u2019s disease. Front Aging Neurosci 6:53\u201353. https:\/\/doi.org\/10.3389\/FNAGI.2014.00053\/BIBTEX","journal-title":"Front Aging Neurosci"},{"issue":"121","key":"11120_CR19","doi-asserted-by":"publisher","first-page":"121ra20","DOI":"10.1126\/SCITRANSLMED.3002566\/SUPPL_FILE\/4-121RA20_SM.PDF","volume":"4","author":"Y Wang","year":"2012","unstructured":"Wang Y, Shi M, Chung KA, Zabetian CP, Leverenz JB, Berg D, Srulijes K, Trojanowski JQ, Lee VMY, Siderowf AD, Hurtig H, Litvan I, Schiess MC, Peskind ER, Masuda M, Hasegawa M, Lin X, Pan C, Galasko D, Goldstein DS, Jensen PH, Yang H, Cain KC, Zhang J (2012) Phosphorylated \u03b1-synuclein in Parkinson\u2019s disease. Sci Transl Med 4(121):121ra20. https:\/\/doi.org\/10.1126\/SCITRANSLMED.3002566\/SUPPL_FILE\/4-121RA20_SM.PDF","journal-title":"Sci Transl Med"},{"issue":"15","key":"11120_CR20","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1002\/MDS.22594","volume":"24","author":"Y Compta","year":"2009","unstructured":"Compta Y, Mart\u00ed MJ, Ibarretxe-Bilbao N, Junqu\u00e9 C, Valldeoriola F, Mu\u00f1oz E, Ezquerra M, R\u00edos J, Tolosa E (2009) Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson\u2019s disease. Mov Disord 24(15):2203\u20132210. https:\/\/doi.org\/10.1002\/MDS.22594","journal-title":"Mov Disord"},{"issue":"2","key":"11120_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14802\/JMD.16017","volume":"9","author":"J-H Kang","year":"2016","unstructured":"Kang J-H (2016) Cerebrospinal fluid amyloid \u03b21-42, tau, and alpha-synuclein predict the heterogeneous progression of cognitive dysfunction in Parkinson\u2019s disease. J Mov Disord 9(2):89\u201396. https:\/\/doi.org\/10.14802\/JMD.16017","journal-title":"J Mov Disord"},{"issue":"15","key":"11120_CR22","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/MDS.23287","volume":"25","author":"TJ Montine","year":"2010","unstructured":"Montine TJ, Shi M, Quinn JF, Peskind ER, Craft S, Ginghina C, Chung KA, Kim H, Galasko DR, Jankovic J, Zabetian CP, Leverenz JB, Zhang J (2010) CSF A\u03b242 and tau in Parkinson\u2019s disease with cognitive impairment. Mov Disord 25(15):2682\u20132685. https:\/\/doi.org\/10.1002\/MDS.23287","journal-title":"Mov Disord"},{"issue":"6","key":"11120_CR23","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/MDS.26578","volume":"31","author":"S Hall","year":"2016","unstructured":"Hall S, Surova Y, \u00d6hrfelt A, Blennow K, Zetterberg H, Hansson O (2016) Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson\u2019s disease. Mov Disord 31(6):898\u2013905. https:\/\/doi.org\/10.1002\/MDS.26578","journal-title":"Mov Disord"},{"issue":"3","key":"11120_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S1474-4422(11)70014-X","volume":"10","author":"B Mollenhauer","year":"2011","unstructured":"Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-D\u00f6ring F, Trenkwalder C, Schlossmacher MG (2011) \u03b1-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Lancet Neurol 10(3):230\u2013240. https:\/\/doi.org\/10.1016\/S1474-4422(11)70014-X","journal-title":"Lancet Neurol"},{"issue":"29","key":"11120_CR25","doi-asserted-by":"publisher","first-page":"15046","DOI":"10.1074\/JBC.M116.736355","volume":"291","author":"T Oikawa","year":"2016","unstructured":"Oikawa T, Nonaka T, Terada M, Tamaoka A, Hisanaga SI, Hasegawa M (2016) \u03b1-Synuclein fibrils exhibit gain of toxic function, promoting tau aggregation and inhibiting microtubule assembly. J Biol Chem 291(29):15046\u201315056. https:\/\/doi.org\/10.1074\/JBC.M116.736355","journal-title":"J Biol Chem"},{"issue":"21","key":"11120_CR26","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1523\/jneurosci.0297-11.2011","volume":"31","author":"EA Waxman","year":"2011","unstructured":"Waxman EA, Giasson BI (2011) Induction of intracellular tau aggregation is promoted by \u03b1-synuclein seeds and provides novel insights into the hyperphosphorylation of tau. J Neurosci 31(21):7604\u20137618. https:\/\/doi.org\/10.1523\/jneurosci.0297-11.2011","journal-title":"J Neurosci"},{"issue":"6","key":"11120_CR27","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/mds.26578","volume":"31","author":"S Hall","year":"2016","unstructured":"Hall S, Surova Y, \u00d6hrfelt A, Study tSB, Blennow K, Zetterberg H, Hansson O (2016) Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson\u2019s disease. Mov Disord 31(6):898\u2013905. https:\/\/doi.org\/10.1002\/mds.26578","journal-title":"Mov Disord"},{"key":"11120_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00415-021-10812-2","volume":"2021","author":"XT Wang","year":"2021","unstructured":"Wang XT, Yu H, Liu FT, Zhang C, Ma YH, Wang J, Dong Q, Tan L, Wang H, Yu JT (2021) Associations of sleep disorders with cerebrospinal fluid \u03b1-synuclein in prodromal and early Parkinson\u2019s disease. J Neurol 2021:1\u201310. https:\/\/doi.org\/10.1007\/S00415-021-10812-2","journal-title":"J Neurol"},{"key":"11120_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/FNEUR.2018.00560\/BIBTEX","volume":"9","author":"M Dolatshahi","year":"2018","unstructured":"Dolatshahi M, Pourmirbabaei S, Kamalian A, Ashraf-Ganjouei A, Yaseri M, Aarabi MH (2018) Longitudinal alterations of alpha-synuclein, amyloid beta, total, and phosphorylated tau in cerebrospinal fluid and correlations between their changes in Parkinson\u2019s disease. Front Neurol 9:560. https:\/\/doi.org\/10.3389\/FNEUR.2018.00560\/BIBTEX","journal-title":"Front Neurol"},{"issue":"10","key":"11120_CR30","doi-asserted-by":"publisher","first-page":"e894","DOI":"10.1212\/WNL.0000000000006134","volume":"91","author":"G Pagano","year":"2018","unstructured":"Pagano G, De Micco R, Yousaf T, Wilson H, Chandra A, Politis M (2018) REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease. Neurology 91(10):e894\u2013e905. https:\/\/doi.org\/10.1212\/WNL.0000000000006134","journal-title":"Neurology"},{"issue":"3","key":"11120_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1212\/WNL.0B013E3181CA0166","volume":"74","author":"RB Postuma","year":"2010","unstructured":"Postuma RB, Gagnon JF, Rompr\u00e9 S, Montplaisir JY (2010) Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology 74(3):239\u2013244. https:\/\/doi.org\/10.1212\/WNL.0B013E3181CA0166","journal-title":"Neurology"},{"key":"11120_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/J.IJMEDINF.2016.03.001","volume":"90","author":"R Prashanth","year":"2016","unstructured":"Prashanth R, Dutta Roy S, Mandal PK, Ghosh S (2016) High-accuracy detection of early Parkinson\u2019s disease through multimodal features and machine learning. Int J Med Inform 90:13\u201321. https:\/\/doi.org\/10.1016\/J.IJMEDINF.2016.03.001","journal-title":"Int J Med Inform"},{"issue":"4","key":"11120_CR33","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/J.AJPATH.2013.12.007\/ATTACHMENT\/7071A905-78FC-4351-AB7D-A52223D76FBA\/MMC1.DOC","volume":"184","author":"T Stewart","year":"2014","unstructured":"Stewart T, Liu C, Ginghina C, Cain KC, Auinger P, Cholerton B, Shi M, Zhang J (2014) Cerebrospinal fluid \u03b1-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort. Am J Pathol 184(4):966\u2013975. https:\/\/doi.org\/10.1016\/J.AJPATH.2013.12.007\/ATTACHMENT\/7071A905-78FC-4351-AB7D-A52223D76FBA\/MMC1.DOC","journal-title":"Am J Pathol"},{"issue":"4","key":"11120_CR34","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3233\/JPD-150682","volume":"5","author":"RE Skogseth","year":"2015","unstructured":"Skogseth RE, Bronnick K, Pereira JB, Mollenhauer B, Weintraub D, Fladby T, Aarsland D (2015) Associations between cerebrospinal fluid biomarkers and cognition in early untreated Parkinson\u2019s disease. J Parkinsons Dis 5(4):783\u2013792. https:\/\/doi.org\/10.3233\/JPD-150682","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"11120_CR35","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"2","key":"11120_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mdc3.12591","volume":"5","author":"C Halsband","year":"2018","unstructured":"Halsband C, Zapf A, Sixel-D\u00f6ring F, Trenkwalder C, Mollenhauer B (2018) The REM sleep behavior disorder screening questionnaire is not valid in de novo Parkinson\u2019s disease. Mov Disord Clin Pract 5(2):171\u2013176. https:\/\/doi.org\/10.1002\/mdc3.12591","journal-title":"Mov Disord Clin Pract"},{"issue":"6","key":"11120_CR37","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00401-016-1552-2","volume":"131","author":"JH Kang","year":"2016","unstructured":"Kang JH, Mollenhauer B, Coffey CS, Toledo JB, Weintraub D, Galasko DR, Irwin DJ, Van Deerlin V, Chen-Plotkin AS, Caspell-Garcia C, Walig\u00f3rska T, Taylor P, Shah N, Pan S, Zero P, Frasier M, Marek K, Kieburtz K, Jennings D, Tanner CM, Simuni T, Singleton A, Toga AW, Chowdhury S, Trojanowski JQ, Shaw LM (2016) CSF biomarkers associated with disease heterogeneity in early Parkinson\u2019s disease: the Parkinson\u2019s Progression Markers Initiative study. Acta Neuropathol 131(6):935\u2013949. https:\/\/doi.org\/10.1007\/s00401-016-1552-2","journal-title":"Acta Neuropathol"},{"issue":"6","key":"11120_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s1474-4422(19)30024-9","volume":"18","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, Mollenhauer B, Blennow K, Calabresi P (2019) CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol 18(6):573\u2013586. https:\/\/doi.org\/10.1016\/s1474-4422(19)30024-9","journal-title":"Lancet Neurol"},{"issue":"19","key":"11120_CR39","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/wnl.0000000000004609","volume":"89","author":"B Mollenhauer","year":"2017","unstructured":"Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, Singleton A, Frasier M, Marek K, Galasko D (2017) Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology 89(19):1959\u20131969. https:\/\/doi.org\/10.1212\/wnl.0000000000004609","journal-title":"Neurology"},{"issue":"3","key":"11120_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/mds.27284","volume":"33","author":"N Abbasi","year":"2018","unstructured":"Abbasi N, Mohajer B, Abbasi S, Hasanabadi P, Abdolalizadeh A, Rajimehr R (2018) Relationship between cerebrospinal fluid biomarkers and structural brain network properties in Parkinson\u2019s disease. Mov Disord 33(3):431\u2013439. https:\/\/doi.org\/10.1002\/mds.27284","journal-title":"Mov Disord"},{"issue":"10","key":"11120_CR41","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1002\/mds.27110","volume":"32","author":"P Eusebi","year":"2017","unstructured":"Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M, Calabresi P, Parnetti L (2017) Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 32(10):1389\u20131400. https:\/\/doi.org\/10.1002\/mds.27110","journal-title":"Mov Disord"},{"issue":"2","key":"11120_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.14336\/AD.2019.0324","volume":"11","author":"F Zhang","year":"2020","unstructured":"Zhang F, Niu L, Liu X, Liu Y, Li S, Yu H, Le W (2020) Rapid eye movement sleep behavior disorder and neurodegenerative diseases: an update. Aging Dis 11(2):315\u2013326. https:\/\/doi.org\/10.14336\/AD.2019.0324","journal-title":"Aging Dis"},{"issue":"2","key":"11120_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11910-019-0918-y","volume":"19","author":"C Liguori","year":"2019","unstructured":"Liguori C, Paoletti FP, Placidi F, Ruffini R, Sancesario GM, Eusebi P, Mercuri NB, Parnetti L (2019) CSF biomarkers for early diagnosis of synucleinopathies: focus on idiopathic RBD. Curr Neurol Neurosci Rep 19(2):3. https:\/\/doi.org\/10.1007\/s11910-019-0918-y","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9","key":"11120_CR44","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1212\/wnl.0000000000001308","volume":"84","author":"Y Hu","year":"2015","unstructured":"Hu Y, Yu SY, Zuo LJ, Cao CJ, Wang F, Chen ZJ, Du Y, Lian TH, Wang YJ, Chan P, Chen SD, Wang XM, Zhang W (2015) Parkinson disease with REM sleep behavior disorder: features, \u03b1-synuclein, and inflammation. Neurology 84(9):888\u2013894. https:\/\/doi.org\/10.1212\/wnl.0000000000001308","journal-title":"Neurology"},{"issue":"2","key":"11120_CR45","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/mds.27232","volume":"33","author":"JG Goldman","year":"2018","unstructured":"Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K, Kang UJ (2018) Cerebrospinal fluid, plasma, and saliva in the BioFIND study: relationships among biomarkers and Parkinson\u2019s disease features. Mov Disord 33(2):282\u2013288. https:\/\/doi.org\/10.1002\/mds.27232","journal-title":"Mov Disord"},{"issue":"12","key":"11120_CR46","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1212\/WNL.0b013e3181f39a78","volume":"75","author":"A Siderowf","year":"2010","unstructured":"Siderowf A, Xie SX, Hurtig H, Weintraub D, Duda J, Chen-Plotkin A, Shaw LM, Van Deerlin V, Trojanowski JQ, Clark C (2010) CSF amyloid beta 1\u201342 predicts cognitive decline in Parkinson disease. Neurology 75(12):1055\u20131061. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f39a78","journal-title":"Neurology"},{"issue":"1","key":"11120_CR47","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s12031-015-0647-x","volume":"58","author":"M Terrelonge Jr","year":"2016","unstructured":"Terrelonge M Jr, Marder KS, Weintraub D, Alcalay RN (2016) CSF \u03b2-amyloid 1\u201342 predicts progression to cognitive impairment in newly diagnosed Parkinson disease. J Mol Neurosci 58(1):88\u201392. https:\/\/doi.org\/10.1007\/s12031-015-0647-x","journal-title":"J Mol Neurosci"},{"issue":"2","key":"11120_CR48","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14802\/jmd.16017","volume":"9","author":"J-H Kang","year":"2016","unstructured":"Kang J-H (2016) Cerebrospinal fluid amyloid \u03b21-42, tau, and alpha-synuclein predict the heterogeneous progression of cognitive dysfunction in Parkinson\u2019s disease. JMD 9(2):89\u201396. https:\/\/doi.org\/10.14802\/jmd.16017","journal-title":"JMD"},{"key":"11120_CR49","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40035-018-0129-5","volume":"7","author":"M Ba","year":"2018","unstructured":"Ba M, Yu G, Kong M, Liang H, Yu L (2018) CSF A\u03b2(1\u201342) level is associated with cognitive decline in early Parkinson\u2019s disease with rapid eye movement sleep behavior disorder. Transl Neurodegener 7:22. https:\/\/doi.org\/10.1186\/s40035-018-0129-5","journal-title":"Transl Neurodegener"},{"issue":"1","key":"11120_CR50","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland D, Batzu L, Halliday GM, Geurtsen GJ, Ballard C, Ray Chaudhuri K, Weintraub D (2021) Parkinson disease-associated cognitive impairment. Nat Rev Dis Primers 7(1):47. https:\/\/doi.org\/10.1038\/s41572-021-00280-3","journal-title":"Nat Rev Dis Primers"},{"key":"11120_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.sleep.2019.12.013","volume":"68","author":"M Figorilli","year":"2020","unstructured":"Figorilli M, Marques AR, Vidal T, Delaby L, Meloni M, Pereira B, Lambert C, Puligheddu M, Durif F, Fantini ML (2020) Does REM sleep behavior disorder change in the progression of Parkinson\u2019s disease? Sleep Med 68:190\u2013198. https:\/\/doi.org\/10.1016\/j.sleep.2019.12.013","journal-title":"Sleep Med"},{"issue":"11","key":"11120_CR52","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s12031-020-01776-5","volume":"71","author":"L Pan","year":"2021","unstructured":"Pan L, Meng L, He M, Zhang Z (2021) Tau in the pathophysiology of Parkinson\u2019s disease. J Mol Neurosci 71(11):2179\u20132191. https:\/\/doi.org\/10.1007\/s12031-020-01776-5","journal-title":"J Mol Neurosci"},{"key":"11120_CR53","doi-asserted-by":"publisher","unstructured":"Kouli A, Torsney KM, Kuan WL (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, Greenland JC (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon Publications. Copyright: The Authors., Brisbane (AU). https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch1","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"issue":"10","key":"11120_CR54","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/mds.26347","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG (2015) REM sleep behavior disorder and neuropathology in Parkinson\u2019s disease. Mov Disord 30(10):1413\u20131417. https:\/\/doi.org\/10.1002\/mds.26347","journal-title":"Mov Disord"},{"issue":"5","key":"11120_CR55","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/mds.27003","volume":"32","author":"D McKenna","year":"2017","unstructured":"McKenna D, Peever J (2017) Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder. Mov Disord 32(5):636\u2013644. https:\/\/doi.org\/10.1002\/mds.27003","journal-title":"Mov Disord"},{"issue":"5","key":"11120_CR56","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1136\/jnnp-2016-314471","volume":"88","author":"A Tekriwal","year":"2017","unstructured":"Tekriwal A, Kern DS, Tsai J, Ince NF, Wu J, Thompson JA, Abosch A (2017) REM sleep behaviour disorder: prodromal and mechanistic insights for Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 88(5):445. https:\/\/doi.org\/10.1136\/jnnp-2016-314471","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"11120_CR57","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/jnnp.2008.149195","volume":"79","author":"RB Postuma","year":"2008","unstructured":"Postuma RB, Gagnon JF, Vendette M, Charland K, Montplaisir J (2008) REM sleep behaviour disorder in Parkinson\u2019s disease is associated with specific motor features. J Neurol Neurosurg Psychiatry 79(10):1117\u20131121. https:\/\/doi.org\/10.1136\/jnnp.2008.149195","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11120-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11120-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11120-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:07:35Z","timestamp":1660043255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11120-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,15]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["11120"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11120-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,15]]},"assertion":[{"value":"28 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest regarding the publication of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This manuscript has been approved for publication by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Since the data in this paper were obtained from the PPMI database (ppmi.loni.usc.edu), it does not include any research involving human or animal subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}